baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Soc. Generale Discount Zert INN1 .../ DE000SW7YU59 /

31.05.2024 12:56:34	Изменение+0.36	Бид22:00:36	Предложение22:00:36	Базовый актив	Цена исполнения	Дата истечения	Тип опциона
15.46EUR	+2.38%	- Величина цены спроса: -	- Величина цены предложения: -	ING GROEP NV EO...	- EUR	27.06.2025	Call

TeleTrader 16:16 Belgium condemns Israel's bid to label UNRWA as terrorist

GlobeNewswire 16:00 SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstr...

GlobeNewswire 16:00 Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Gli...

GlobeNewswire 16:00 Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates M...

TeleTrader 15:23 Macron backs Biden's ceasefire proposal for Gaza

GlobeNewswire 15:14 Flash News: OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures Listing

GlobeNewswire 15:00 ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Ther...

GlobeNewswire 15:00 Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monothera...

TeleTrader 14:35 ANC loses 30-year majority in S. Africa

GlobeNewswire 14:15 FSLY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fastly, Inc. Investors with ...

GlobeNewswire 14:15 Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting

GlobeNewswire 14:05 Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting

GlobeNewswire 14:00 Kaskela Law LLC Announces Shareholder Investigation of WideOpenWest, Inc. (NYSE: WOW) and Encourages...

GlobeNewswire 14:00 Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonst...

GlobeNewswire 14:00 Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin)...

GlobeNewswire 14:00 OkayCoin CEO Releases Key Strategies to Maximize Investor Returns on Staking Platform

GlobeNewswire 14:00 Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at...

GlobeNewswire 14:00 CryptoHeap Targets Top Position in Crypto Staking Industry Before Bull Run Concludes

GlobeNewswire 14:00 Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confi...

GlobeNewswire 13:55 ENPH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors...

TeleTrader 13:41 Netanyahu: Ceasefire tied to Hamas dismantling

GlobeNewswire 13:00 Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipa...

TeleTrader 12:43 Gaza Health Ministry: Death toll rises to 36,379

TeleTrader 11:49 Indonesia's Prabowo ready to send peacekeepers to Gaza

GlobeNewswire 11:42 VENTYX SHAREHOLDER REMINDER: BFA Law Reminds Ventyx Biosciences, Inc. (NASDAQ: VTYX) Shareholders to...

Soc. Generale Discount Zert INN1 .../ DE000SW7YU59 /

Если вы хотите получить ответ на свой отзыв, укажите, пожалуйста, адрес своей электронной почты.